Table 4.
Clinicopathologic features of patients with recurrence
| No. | Age at diagnosis | T stage | Loco-regional Treatment | Systemic adjuvant treatment | ER | PR | HER2 | Site of recurrent disease | RFS (months) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 31 | T1mic | BCS | None | + | + | - | Remnant breast | 37.5 |
| 2 | 36 | T1mic | BCS, RTx | None | + | - | + | Remnant breast | 21.1 |
| 3 | 50 | T1mic | BCS, RTx | None | - | - | - | Remnant breast | 20.2 |
| 4 | 35 | T1mic | Mastectomy | None | - | - | + | Lung | 69.9 |
| 5 | 62 | T1a | BCS, RTx | None | - | - | Unknown | Remnant breast | 31.6 |
| 6 | 29 | T1a | Mastectomy | Hormone therapy | + | + | - | Chest wall | 30.3 |
| 7 | 52 | T1b | BCS | Chemotherapy | - | - | - | Remnant breast | 39.9 |
| 8 | 38 | T1b | BCS, RTx | Chemotherapy | - | - | + | Lung, Skin | 29.5 |
| 9 | 52 | T1b | Mastectomy | None | - | - | - | Lung | 6.1 |
| 10 | 53 | T1b | BCS, RTx | Chemotherapy | - | - | - | Remnant breast | 27 |
| 11 | 38 | T1b | Mastectomy | Hormone therapy | + | + | - | Remnant breast | 26.6 |
| 12 | 60 | T1b | Mastectomy | None | + | - | - | Remnant breast | 121.2 |
Abbreviation: BCS, breast conserving surgery; RTx, radiotherapy